High-Dose Compound Heat Map for 3D-Cultured Glioblastoma Multiforme Cells in a Micropillar and Microwell Chip Platform

Glioblastoma multiforme (GBM) is recognized as the most common and lethal form of central nervous system cancer. To cure GBM patients, many target-specific chemotherapeutic agents have been developing. However, 2D monolayer cell-based toxicity and efficacy tests did not efficiently screen agents due to the pool reflection of in vivo microenvironments (cell-to-cell and cell-to-extracellular matrix interaction). In this study, we used a 3D cell-based, high-throughput screening method reflecting the microenvironments using a micropillar and microwell chip platform to draw a high-dose heat map of the cytotoxicity and efficacy of 70 compounds, with two DMSO controls. Moreover, the high-dose heat map model compared the responses of four 3D-cultured patient-derived GBM cells and astrocytes to high dosages of compounds with respect to efficacy and cytotoxicity, respectively, to discern the most efficacious drug for GBM. Among the 70 compounds tested, cediranib (a potent inhibitor of vascular endothelial growth factor (VEGF) receptor tyrosine kinases) exhibited the lowest cytotoxicity to astrocytes and high efficacy to GBM cells in a high-dose heat map model.

[1]  A. Levchenko,et al.  Migration Phenotype of Brain-Cancer Cells Predicts Patient Outcomes. , 2016, Cell reports.

[2]  C. Howarth,et al.  The role of astrocytes in CNS tumors: pre-clinical models and novel imaging approaches , 2013, Front. Cell. Neurosci..

[3]  Sang Hyun Yi,et al.  Plastic pillar inserts for three-dimensional (3D) cell cultures in 96-well plates , 2013 .

[4]  Krister Wennerberg,et al.  Impact of normalization methods on high-throughput screening data with high hit rates and drug testing with dose–response data , 2015, Bioinform..

[5]  T. Batchelor,et al.  Cediranib: profile of a novel anti-angiogenic agent in patients with glioblastoma , 2009, Expert opinion on investigational drugs.

[6]  R. Shoemaker.  The NCI60 human tumour cell line anticancer drug screen , 2006, Nature Reviews Cancer.

[7]  R. Mirimanoff,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[8]  Emma East,et al.  A 3D in vitro model reveals differences in the astrocyte response elicited by potential stem cell therapies for CNS injury. , 2013, Regenerative medicine.

[9]  Katrina Stevenson,et al.  A novel 3D human glioblastoma cell culture system for modeling drug and radiation responses , 2016, Neuro-oncology.

[10]  D. Geschwind,et al.  Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture , 2015, Nature Methods.

[11]  Sang Youl Jeon,et al.  High-throughput, miniaturized clonogenic analysis of a limiting dilution assay on a micropillar/microwell chip with brain tumor cells. , 2014, Small.

[12]  B. Rosen,et al.  Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation , 2013, Proceedings of the National Academy of Sciences.

[13]  L. Soroceanu,et al.  Selective Toxicity of a Highly Potent Camptothecin Analogue: A Pilot Study with Glioblastoma Multiforme Cells. , 2016, Anticancer research.

[14]  Gary D Bader,et al.  Inhibition of Dopamine Receptor D4 Impedes Autophagic Flux, Proliferation, and Survival of Glioblastoma Stem Cells. , 2016, Cancer cell.

[15]  U. Linz.  Commentary on effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5‐Year analysis of the EORTC‐NCIC trial (Lancet Oncol. 2009;10:459‐466) , 2010, Cancer.

[16]  J. Fike,et al.  CNS complications of radiotherapy and chemotherapy , 2009, The Lancet.

[17]  R. Mirimanoff,et al.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. , 2009, The Lancet. Oncology.

[18]  Sang Hyun Yi,et al.  High-throughput screening (HTS) of anticancer drug efficacy on a micropillar/microwell chip platform. , 2014, Analytical chemistry.

[19]  Shuichi Takayama,et al.  High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array. , 2011, The Analyst.

[20]  Dong Woo Lee,et al.  High-Throughput Clonogenic Analysis of 3D-Cultured Patient-Derived Cells with a Micropillar and Microwell Chip , 2017, SLAS discovery : advancing life sciences R & D.

[21]  B. Lukomska,et al.  The role of astrocytes in the physiology and pathology of the central nervous system. , 2006, Acta neurobiologiae experimentalis.

[22]  Dong Woo Lee,et al.  Automatic 3D Cell Analysis in High-Throughput Microarray Using Micropillar and Microwell Chips , 2015, Journal of biomolecular screening.